GB1214135A - Vaccines - Google Patents
VaccinesInfo
- Publication number
- GB1214135A GB1214135A GB8232/67A GB823267A GB1214135A GB 1214135 A GB1214135 A GB 1214135A GB 8232/67 A GB8232/67 A GB 8232/67A GB 823267 A GB823267 A GB 823267A GB 1214135 A GB1214135 A GB 1214135A
- Authority
- GB
- United Kingdom
- Prior art keywords
- virus
- dialysis
- precipitate
- suspension
- viruses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229960005486 vaccine Drugs 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 8
- 238000000502 dialysis Methods 0.000 abstract 4
- 239000002244 precipitate Substances 0.000 abstract 3
- 239000000725 suspension Substances 0.000 abstract 3
- 229960003971 influenza vaccine Drugs 0.000 abstract 2
- 150000001457 metallic cations Chemical class 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- 239000007900 aqueous suspension Substances 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 235000013601 eggs Nutrition 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 230000000415 inactivating effect Effects 0.000 abstract 1
- 206010022000 influenza Diseases 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 238000000464 low-speed centrifugation Methods 0.000 abstract 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000010414 supernatant solution Substances 0.000 abstract 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 abstract 1
- 235000011046 triammonium citrate Nutrition 0.000 abstract 1
- 239000001393 triammonium citrate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16251—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8232/67A GB1214135A (en) | 1967-02-21 | 1967-02-21 | Vaccines |
| US704216A US3632745A (en) | 1967-02-21 | 1968-02-09 | Concentration and purification of influenza viruses |
| IL29444A IL29444A (en) | 1967-02-21 | 1968-02-09 | Method for the preparation of vaccines from viruses of the influenza group |
| CH243068A CH540338A (de) | 1967-02-21 | 1968-02-20 | Verfahren zur Anreicherung und Reinigung einer Viren der Influenzagruppe enthaltenden Suspension und deren Verwendung zur Herstellung von inaktivierten Viren |
| ES350690A ES350690A1 (es) | 1967-02-21 | 1968-02-20 | Un metodo para la concentracion y purificacion de los virusdel grupo de la influenza. |
| DE19681667929 DE1667929A1 (de) | 1967-02-21 | 1968-02-21 | Vakzine |
| BE711116D BE711116A (cg-RX-API-DMAC10.html) | 1967-02-21 | 1968-02-21 | |
| FR1592089D FR1592089A (cg-RX-API-DMAC10.html) | 1967-02-21 | 1968-02-21 | |
| NL6802466A NL6802466A (cg-RX-API-DMAC10.html) | 1967-02-21 | 1968-02-21 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8232/67A GB1214135A (en) | 1967-02-21 | 1967-02-21 | Vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1214135A true GB1214135A (en) | 1970-12-02 |
Family
ID=9848505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB8232/67A Expired GB1214135A (en) | 1967-02-21 | 1967-02-21 | Vaccines |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3632745A (cg-RX-API-DMAC10.html) |
| BE (1) | BE711116A (cg-RX-API-DMAC10.html) |
| CH (1) | CH540338A (cg-RX-API-DMAC10.html) |
| DE (1) | DE1667929A1 (cg-RX-API-DMAC10.html) |
| ES (1) | ES350690A1 (cg-RX-API-DMAC10.html) |
| FR (1) | FR1592089A (cg-RX-API-DMAC10.html) |
| GB (1) | GB1214135A (cg-RX-API-DMAC10.html) |
| IL (1) | IL29444A (cg-RX-API-DMAC10.html) |
| NL (1) | NL6802466A (cg-RX-API-DMAC10.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3860515A (en) * | 1973-10-31 | 1975-01-14 | Atomic Energy Commission | Method for concentrating macromolecules |
| US3874999A (en) * | 1973-10-31 | 1975-04-01 | American Cyanamid Co | Process for the purification of virus vaccine |
| AT406535B (de) * | 1988-03-18 | 2000-06-26 | Singerewitsch Boris | Vorrichtung zur erwärmung eines strömenden mediums, insbesondere wasser |
| AU2004249802B2 (en) * | 2003-06-20 | 2007-06-28 | Microbix Biosystems Inc. | Improvements in virus production |
| EP1878791A1 (en) | 2006-07-11 | 2008-01-16 | Bia Separations D.O.O. | Method for influenza virus purification |
-
1967
- 1967-02-21 GB GB8232/67A patent/GB1214135A/en not_active Expired
-
1968
- 1968-02-09 US US704216A patent/US3632745A/en not_active Expired - Lifetime
- 1968-02-09 IL IL29444A patent/IL29444A/en unknown
- 1968-02-20 ES ES350690A patent/ES350690A1/es not_active Expired
- 1968-02-20 CH CH243068A patent/CH540338A/de not_active IP Right Cessation
- 1968-02-21 FR FR1592089D patent/FR1592089A/fr not_active Expired
- 1968-02-21 DE DE19681667929 patent/DE1667929A1/de active Pending
- 1968-02-21 BE BE711116D patent/BE711116A/xx unknown
- 1968-02-21 NL NL6802466A patent/NL6802466A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US3632745A (en) | 1972-01-04 |
| BE711116A (cg-RX-API-DMAC10.html) | 1968-08-21 |
| NL6802466A (cg-RX-API-DMAC10.html) | 1968-08-22 |
| FR1592089A (cg-RX-API-DMAC10.html) | 1970-05-11 |
| ES350690A1 (es) | 1969-05-16 |
| DE1667929A1 (de) | 1971-06-16 |
| IL29444A (en) | 1971-12-29 |
| CH540338A (de) | 1973-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Takemoto et al. | Virus-polysaccharide interactions: I. An agar polysaccharide determining plaque morphology of EMC virus | |
| Wheelock et al. | Participation of lymphocytes in viral infections | |
| ATE162402T1 (de) | Oraler an der oberfläche von erythrozyten gebundene antigene beinhaltender impfstoff | |
| GB1183506A (en) | New vaccines for combating influenza and the preparation thereof | |
| Levy-Koenig et al. | Immunology of Interferons: II. Heterospecific Activities of Human Interferons and Their Neutralization by Antibody | |
| GB1170679A (en) | Process for Stabilizing Preparations of Interfering Viruses | |
| ES350690A1 (es) | Un metodo para la concentracion y purificacion de los virusdel grupo de la influenza. | |
| Mendelson et al. | The in vitro and in vivo effects of cortisol on interferon production and action | |
| FR2399252A1 (fr) | Vaccin de masse moleculaire elevee contre la meningite a meningocoques du groupe c et procede pour sa preparation | |
| Brown et al. | Studies with infective ribonucleic acid from tissues and cell cultures infected with the virus of foot-and-mouth disease | |
| Wilcox et al. | Soluble Antigens of Vaccinia-infected Mammalian Cells II. Time Course of Synthesis of Soluble Antigens and Virus Structural Proteins | |
| US4057626A (en) | Process for detoxifying influenza B virus | |
| EP0833903A4 (en) | MULTIVALENT VACCINE AGAINST BOVINES CORONAVIRUS AND METHOD FOR TREATING AN INFECTION WITH BOVIN CORONAVIRUS | |
| Howie | Spawning mechanism in the male lugworm | |
| Rudent et al. | Enhanced resistance of mice against influenza virus infection after local administration of glycoprotein extracts from Klebsiella pneumoniae | |
| Russell et al. | Mumps Viral Cytolysin: I. Action on Human Epithelial Cells in Tissue Culture | |
| GB1226743A (cg-RX-API-DMAC10.html) | ||
| GB660109A (en) | Improvements in or relating to the treatment of allantoic fluid containing a propagated virus together with non-viral proteins to obtain the virus in purified and viable from for use in a vaccine | |
| Oh | Sensitivity of types 1 and 2 Herpesvirus hominis to an interferon inducer, poly I: C | |
| Iwasaki et al. | Communications: Effect of Lymphocytosis-Promoting Factor (LPF) on the Appearance of Antibodies in Mice Infected with Influenza Virus | |
| US3629470A (en) | Process for purification of animal rna viruses | |
| US2981658A (en) | Lipid purification and concentration of viruses and vaccines therefrom | |
| DK306379A (da) | Herpesvirusvaccine | |
| GB1300567A (en) | Therapeutic compositions | |
| SE308902B (cg-RX-API-DMAC10.html) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |